Guardian Pharmacy Services, Stock Buy Hold or Sell Recommendation
| GRDN Stock | 20.09 0.76 3.93% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Guardian Pharmacy Services, is 'Hold'. The recommendation algorithm takes into account all of Guardian Pharmacy's available fundamental, technical, and predictive indicators you will find on this site.
Check out Guardian Pharmacy Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Guardian and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Guardian Pharmacy Services,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
Guardian |
Execute Guardian Pharmacy Buy or Sell Advice
The Guardian recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Guardian Pharmacy Services,. Macroaxis does not own or have any residual interests in Guardian Pharmacy Services, or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Guardian Pharmacy's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | Very Weak | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Responds to the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Guardian Pharmacy Trading Alerts and Improvement Suggestions
| Guardian Pharmacy generated a negative expected return over the last 90 days | |
| Guardian Pharmacy has high historical volatility and very poor performance | |
| Guardian Pharmacy has a frail financial position based on the latest SEC disclosures | |
| Over 99.0% of the company shares are owned by institutional investors |
Guardian Pharmacy Returns Distribution Density
The distribution of Guardian Pharmacy's historical returns is an attempt to chart the uncertainty of Guardian Pharmacy's future price movements. The chart of the probability distribution of Guardian Pharmacy daily returns describes the distribution of returns around its average expected value. We use Guardian Pharmacy Services, price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Guardian Pharmacy returns is essential to provide solid investment advice for Guardian Pharmacy.
| Mean Return | -0.12 | Value At Risk | -6.11 | Potential Upside | 4.34 | Standard Deviation | 3.46 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Guardian Pharmacy historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Guardian Pharmacy Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Guardian Pharmacy or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Guardian Pharmacy's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Guardian stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.04 | |
β | Beta against Dow Jones | 1.47 | |
σ | Overall volatility | 3.46 | |
Ir | Information ratio | -0.0046 |
Guardian Pharmacy Volatility Alert
Guardian Pharmacy Services, exhibits very low volatility with skewness of 0.37 and kurtosis of 0.61. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Guardian Pharmacy's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Guardian Pharmacy's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Guardian Pharmacy Fundamentals Vs Peers
Comparing Guardian Pharmacy's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Guardian Pharmacy's direct or indirect competition across all of the common fundamentals between Guardian Pharmacy and the related equities. This way, we can detect undervalued stocks with similar characteristics as Guardian Pharmacy or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Guardian Pharmacy's fundamental indicators could also be used in its relative valuation, which is a method of valuing Guardian Pharmacy by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Guardian Pharmacy to competition |
| Fundamentals | Guardian Pharmacy | Peer Average |
| Profit Margin | (0.07) % | (1.27) % |
| Operating Margin | (0.33) % | (5.51) % |
| Current Valuation | 1.29 B | 16.62 B |
| Shares Outstanding | 9.2 M | 571.82 M |
| Shares Owned By Insiders | 0.96 % | 10.09 % |
| Shares Owned By Institutions | 99.04 % | 39.21 % |
| Number Of Shares Shorted | 753.91 K | 4.71 M |
| Price To Book | 9.80 X | 9.51 X |
| Price To Sales | 1.07 X | 11.42 X |
| Revenue | 1.05 B | 9.43 B |
| Gross Profit | 231.84 M | 27.38 B |
| EBITDA | (44.82 M) | 3.9 B |
| Net Income | 23.9 M | 570.98 M |
| Total Debt | 12.98 M | 5.32 B |
| Book Value Per Share | 2.02 X | 1.93 K |
| Cash Flow From Operations | 70.82 M | 971.22 M |
| Short Ratio | 8.66 X | 4.00 X |
| Earnings Per Share | (1.38) X | 3.12 X |
| Target Price | 24.33 | |
| Number Of Employees | 10 | 18.84 K |
| Market Capitalization | 1.25 B | 19.03 B |
| Total Asset | 271.17 M | 29.47 B |
| Working Capital | (8.41 M) | 1.48 B |
| Net Asset | 271.17 M |
Guardian Pharmacy Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Guardian . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Guardian Pharmacy Buy or Sell Advice
When is the right time to buy or sell Guardian Pharmacy Services,? Buying financial instruments such as Guardian Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Guardian Pharmacy in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Heavy Metals Thematic Idea Now
Heavy Metals
Companies involved in mining, production, and distribution of various industrial metals and minerals. The Heavy Metals theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Heavy Metals Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Guardian Pharmacy Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Retail space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardian Pharmacy. If investors know Guardian will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardian Pharmacy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Guardian Pharmacy is measured differently than its book value, which is the value of Guardian that is recorded on the company's balance sheet. Investors also form their own opinion of Guardian Pharmacy's value that differs from its market value or its book value, called intrinsic value, which is Guardian Pharmacy's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardian Pharmacy's market value can be influenced by many factors that don't directly affect Guardian Pharmacy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardian Pharmacy's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardian Pharmacy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardian Pharmacy's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.